J. Jill Hopkins, M.D., is a distinguished medical professional and executive, currently serving as the Chief Medical Officer and President of Research and Development at AURA BIOSCIENCES INC. Dr. Hopkins has a robust background in oncology and ophthalmology, having earned her medical degree from Harvard Medical School. Her career is marked by significant contributions to the development of novel therapies, particularly in the field of cancer treatment. Prior to joining AURA BIOSCIENCES, Dr. Hopkins held pivotal roles at major pharmaceutical companies, where she spearheaded clinical development programs and fostered collaborations that advanced the treatment landscape for various cancers. In her current role at AURA BIOSCIENCES, Dr. Hopkins is instrumental in guiding the company's strategic direction in research and development. She oversees the clinical trials and development of AURA's lead candidate, a groundbreaking therapy designed to treat ocular cancers. Her leadership has been crucial in navigating the complex regulatory pathways necessary to bring innovative treatments to market. Dr. Hopkins' expertise in both clinical and translational research has not only propelled AURA BIOSCIENCES forward but has also contributed to the broader scientific community through her published works and presentations at international conferences. Dr. Hopkins' achievements extend beyond her corporate roles. She is an active member of several professional organizations, including the American Society of Clinical Oncology and the Association for Research in Vision and Ophthalmology. Her commitment to advancing medical science is evident in her mentorship of young researchers and her advocacy for patient-centric approaches in drug development. Under her guidance, AURA BIOSCIENCES continues to make strides in the fight against cancer, embodying her vision of transforming patient care through cutting-edge research and development.